← Open Payments lookup

MIRANDA VANCIL: Open Payments

NPI 1932637725 · ANDOVER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,482 in 81 payments from 22 companies in 2025. Trend: 2023 $1,217 · 2024 $1,493 · 2025 $1,482

Food & beverage: $1,482
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$164
Lilly USA, LLC9$162
GlaxoSmithKline, LLC.7$161
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$156
ABBVIE INC.12$153
Astellas Pharma US Inc6$126
Bayer Healthcare Pharmaceuticals Inc.7$107
Sumitomo Pharma America, Inc.4$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$54
Amgen Inc.3$49

Products named: XIFAXAN, BREZTRI, TRELEGY ELLIPTA, Veozah, Kerendia, MOUNJARO, QULIPTA, UBRELVY.

Industry payments across KS — which companies pay providers there.